greeksoup/ stock research

Cardinal Health (CAH) FY2023 results: revenue $205.0 billion, up 13.0% on the year

Cardinal Health Inc. (CAH) reported revenue of $205.0 billion for fiscal 2023, the year ended 30 June 2023, up 13.0% on the year before. Net income was $330 million, and diluted earnings per share $1.26. The figures are the company's own, from the 10-K it filed with the SEC on 15 August 2023.

Revenue
$205.0 billion
+13.0% on the year
FY2016FY2023
Operating margin
0.4%
-0.3% a year earlier
FY2016FY2023
Net income
$330 million
FY2016FY2023
Diluted EPS
$1.26
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue205,012181,364162,467+13.0%
Cost of revenue198,123174,819155,689+13.3%
Gross profit6,8746,4846,778+6.0%
Gross margin3.4%3.6%4.2%
Selling, general and administrative4,8004,5124,533+6.4%
Operating income752-607472
Operating margin0.4%-0.3%0.3%
Interest expense84.0147180-42.9%
Pre-tax income663-784323
Income tax332153-289+117.0%
Effective tax rate50.1%n/a-89.5%
Net income330-938611
Net margin0.2%-0.5%0.4%
Diluted EPS$1.26-$3.37$2.08
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow2,8393,1752,429-10.6%
Capital expenditure481387400+24.3%
Free cash flow2,3582,7882,029-15.4%
Free cash flow margin1.2%1.5%1.2%
Cash from investing-454567-378
Cash from financing-3,051-2,463-1,317
Depreciation and amortisation6926927830.0%
Share-based compensation96.081.089.0+18.5%
Buybacks2,0001,000200+100.0%
Dividends paid525559573-6.1%
Dividend per share$1.98$1.96$1.94+1.0%
Diluted shares, weighted262m279m294m-6.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity-2,958-7091,791
Non-controlling interest1.03.03.0-66.7%
Debt4,7005,3006,200-11.3%
Operating lease liabilities375388374-3.4%
Finance lease liabilities59.049.045.0+20.4%
Other liabilities41,24038,84736,040+6.2%
Total liabilities and equity43,41743,87844,453-1.1%
Fixed assets2,4622,3612,360+4.3%
Goodwill4,6095,8557,989-21.3%
Intangible assets1,4721,7742,105-17.0%
Cash and equivalents4,0764,7173,407-13.6%
Receivables11,10810,5619,103+5.2%
Inventory16,11915,63614,594+3.1%
Other assets3,5712,9744,895+20.1%
Total assets43,41743,87844,453-1.1%

10-K for the year ended 30 June 2023, filed 15 August 2023: the filing.